Chengdu Syncor Pharmaceutical Co., Ltd.

This early-stage trial is testing a new radioactive drug called BPR-6023021 in people with advanced cancers that have spread to their bones. The main goals are to find a safe dose and see if the drug can help control the cancer's growth in the bones and delay bone-related complic…

This study aims to see if adding a new oral capsule called BPR-101 to a standard antibiotic (metronidazole) can help prevent bacterial vaginosis (BV) from recurring. It will involve about 80 women aged 18-50 who have been diagnosed with BV. The trial will compare the new combinat…